Role of human HGFIN/nmb in breast cancer
2007

The Role of HGFIN in Breast Cancer

Sample size: 50 publication 10 minutes Evidence: moderate

Author Information

Author(s): Rebecca L Metz, Prem S Patel, Meera Hameed, Margaret Bryan, Pranela Rameshwar

Primary Institution: UMDNJ-New Jersey Medical School

Hypothesis

HGFIN may act as a tumor suppressor in breast cancer by regulating cell growth and migration.

Conclusion

HGFIN expression is reduced in malignant breast cancer cells, suggesting it may play a role in tumor suppression.

Supporting Evidence

  • HGFIN expression is significantly higher in non-tumorigenic breast cells compared to malignant cells.
  • Knockout of HGFIN in non-tumorigenic cells leads to increased cell growth and migration.
  • Ectopic expression of HGFIN in breast cancer cells reduces their growth and migration.

Takeaway

HGFIN is a protein that helps keep breast cells healthy, and when it's missing, the cells can become cancerous and grow uncontrollably.

Methodology

The study used siRNA to knock out HGFIN in non-tumorigenic breast cells and ectopically expressed HGFIN in breast cancer cells, along with in situ hybridization and reporter gene assays.

Potential Biases

Potential bias in patient selection and hormonal status not being controlled.

Limitations

The study primarily focused on one variant of HGFIN and did not explore the effects of other variants.

Participant Demographics

Patients diagnosed with infiltrating ductal carcinomas, with varying hormone receptor statuses.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/bcr1764

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication